Millipore Sigma Vibrant Logo

110150 N-Acetyl-D-glucosaminyl-(β1,4)-N-acetylmuramyl-L-alanyl-D-isoglutamine

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: GMDP

110150
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information
      Description
      OverviewImmunomodulator peptide with immunoadjuvant and protective activity against bacterial and viral infections. Exhibits tumorigenic and somnogenic effects. Unlike muramyl peptides, contains GlcNAc attached to muramic acid of muramyl peptide via β1,4 glycosidic bond. Poorly permeable through intestinal wall. However, its bioavailability can be increased by using it in water-in-oil microemulsion.
      Catalogue Number110150
      Brand Family Calbiochem®
      SynonymsGMDP
      References
      ReferencesLyons, K.C., et al. 2000. Int. J. Pharm. 199, 17.
      Campbell, M., et al. 1990. J. Immunol. 145, 1029.
      Product Information
      CAS number70280-03-4
      FormLyophilized
      Hill FormulaC₂₇H₄₄N₅O₁₆
      Chemical formulaC₂₇H₄₄N₅O₁₆
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      110150 0

      Documentation

      N-Acetyl-D-glucosaminyl-(β1,4)-N-acetylmuramyl-L-alanyl-D-isoglutamine Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      N-Acetyl-D-glucosaminyl-(β1,4)-N-acetylmuramyl-L-alanyl-D-isoglutamine Certificados de análisis

      CargoNúmero de lote
      110150

      Referencias bibliográficas

      Visión general referencias
      Lyons, K.C., et al. 2000. Int. J. Pharm. 199, 17.
      Campbell, M., et al. 1990. J. Immunol. 145, 1029.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-April-2008 RFH
      SynonymsGMDP
      DescriptionImmunomodulator peptide with immunoadjuvant and protective activity against bacterial and viral infections. Exhibits tumorigenic and somnogenic effects. Unlike muramyl peptides, contains GlcNAc attached to muramic acid of muramyl peptide via β1,4 glycosidic bond. Poorly permeable through intestinal wall. However, its bioavailability can be increased by using it in water-in-oil microemulsion.
      FormLyophilized
      CAS number70280-03-4
      Chemical formulaC₂₇H₄₄N₅O₁₆
      Purity≥97% by HPLC
      SolubilityH₂O (1 mg/ml) or PBS (1 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesLyons, K.C., et al. 2000. Int. J. Pharm. 199, 17.
      Campbell, M., et al. 1990. J. Immunol. 145, 1029.